gvtcx

PHE_Scientific_Provision of purchase of SARS-CoV-2 (2019-nCoV) Spike RBD

Public Health England Published 9 Apr 2021 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£26,094
Statuscomplete
Category (CPV) 33000000 +1 more
Deadline1 Apr 2021
Contract start2 Apr 2021
Contract end31 Mar 2022
Procedureselective
SME suitableYes
OCIDocds-b5fd17-9f8e7ee2-a9cf-40dd-9008-fcf12b76cb93

Award

SupplierValueDateStatus
Stratech Scientific Ltd £26,094 31 Mar 2021 active

description

The Government must protect the health and well-being of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 Jan 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 Mar 2020.

PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004).

Public Health England (PHE) has awarded a contract for the purchase of Spike RBD Antibody, Antigen Affinity Purified to Stratech Scientific Ltd, via direct award under PHE Microbiology Framework - Lot 2.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
9 Apr 2021 Award (award) · 55f4790a-a088-4925-9ed6-6b31f1261cf3-427527

more from Public Health England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.